molecules-logo

Journal Browser

Journal Browser

Announcements

17 December 2024
Over 100 German Universities Partner with MDPI in New National Agreement


More than 100 German universities and research institutions have entered into a national agreement with MDPI. The publication agreement negotiated by ZB MED comes into effect on 1 January 2025 and is valid until the end of 2026. Joining the consortium is still possible until the beginning of 2025. We are delighted by the high level of interest this agreement has already garnered, reflecting the strong demand for accessible and cost-effective open access publishing solutions among German research institutions.

This new cooperation aims to make scientific gold open access publishing more affordable and less administratively burdensome for researchers in Germany. The agreement includes substantial discounts on article processing charges (APCs) for corresponding authors from participating institutions. It offers flexible payment options, including centralized invoicing or individual payment of fees by researchers or their institutions. Additionally, the agreement features a flat-fee model that enables institutions to precisely plan expenses and optimize their library budgets.

"MDPI can look back on over a decade of successful partnerships with German research institutions," says Peter Roth, MDPI Head of Publishing. "The new agreement marks another milestone in the long-standing co-operation between MDPI and the German scientific community. It emphasizes our commitment to developing up-to-date and inventive solutions for the diverse needs of scientific institutions to promote open research for the benefit of researchers."

Petra Labriga, Head of Strategic License Management at ZB MED, highlighted the agreement's significance: "As one of the world's leading Gold OA publishers, MDPI plays a central role in the German publishing landscape. We are particularly pleased that we were able to achieve considerable potential cost savings for scientific institutions and their authors at a national level through our negotiations."

The partnership reflects a common goal of advancing the idea of open access and supporting researchers in making their scientific excellence internationally visible.

"We would like to thank the ZB MED consortium team for their excellent collaboration," added Adrian Stefan Zamfir, MDPI Institutional Partnership Manager for the DACH region. "We are delighted that this agreement will give even more researchers in Germany access to our tried-and-tested and reliable publication platform."

Franziska Fischer (right), Commercial Director at ZB MED, an Peter Roth (left), Head of Publishing at MDPI, celebrate the signing of the new national open access agreement between MDPI and the ZB MED Consortium.

Peter Roth (center) joined ZB MED's Lea Carolina Schindler, Petra Labriga, Franziska Fischer, and Jonathan Lehmann in Cologne, Germany, on 13 December 2024 to sign the agreement.

More Information

  • Conditions and participation opportunities (German): Link
  • Frequently asked questions (German): Link

Contact


About ZB MED

ZB MED - Information Centre for Life Sciences is an infrastructure and research centre for life science information and data. Its aim is to support and strengthen research for people and the environment: from medicine to biodiversity and environmental protection.

The work of ZB MED is orientated towards the strategic guidelines:

  • Research + Networking: We conduct research together with the regionally, nationally, European and globally networked research community.
  • Data science: We enable data analyses and generate new knowledge through research.
  • Access to information: We provide sustainable access to information, literature and data as a central information infrastructure.
  • Open + FAIR: We promote open and reproducible science in line with open science and FAIR principles.
  • Knowledge and skills transfer: We actively impart knowledge, competences and skills.

More information at www.zbmed.de.

About MDPI

Headquartered in Basel, Switzerland, MDPI is one of the world's leading open access publishers with a current portfolio of more than 440 journals in all scientific disciplines. MDPI‘s goal is to advance open science worldwide through greater transparency, efficiency and collaboration. To date, more than 3.7 million researchers have published their results in MDPI journals. The editorial process is overseen by a large network of dedicated reviewers and editors and supported by more than 6500 MDPI employees. MDPI currently works with over 800 academic institutions and 180 scientific societies worldwide, which benefit from a wide range of MDPI services and products.

17 December 2024
Article Layout and Template Revised for Future Volumes

We are pleased to announce a series of updates to our template, aimed at improving the readability and overall aesthetics of our publications. These changes have been meticulously designed to enhance the user experience and ensure consistency across all our publications. The updated template will be available for download from the Instructions for Authors page.

The following updates will be applied to articles published in the 2025 volumes, starting on 24 December 2024:

  • Main text: The line spacing has been increased to improve the readability of publications;
  • Header and footer: The link to the journal website will be removed, as a hyperlink has been integrated into the journal logo. Additionally, the DOI link will be moved from the left-hand side to the right-hand side, and both the header and footer will be slightly raised to achieve a better balance;
  • Left information bar: The information provided here has been rearranged for better organization; the CC-BY logo will be removed;
  • Font size: The font size used for the abstract, keywords, and first-level headings will be increased.

Furthermore, MDPI journals will continue to use article numbers. This approach enables us to maintain a rapid and efficient production process by being able to define pagination as soon as a paper is accepted.

We hope that the new version of the template will provide users with a better experience and make the process more convenient.

Please contact production@mdpi.com if you have any questions or suggestions.

6 December 2024
Meet Us Online at the 3rd International Electronic Conference on Biomedicines, 12–15 May 2025


Conference: 3rd International Electronic Conference on Biomedicines
Time: 12–15 May 2025, CEST, Online
Website: https://sciforum.net/event/ECB2025

We cordially invite you to attend the above event organized by the MDPI journal Biomedicines (ISSN: 2227-9059; Impact Factor: 3.9). The conference will take place virtually on 12–15 May 2025, CEST.

Conference Chairs:

  • Prof. Dr. Felipe Fregni, Harvard Medical School, Boston, MA, USA;
  • Prof. Dr. Allan Stensballe, Aalborg University, Aalborg, Denmark;
  • Prof. Dr. Georgia Levidou, Paracelsus Medical University, Klinikum Nuremberg, Germany;
  • Prof. Dr. Serafino Fazio, Federico II University School of Medicine, Naples, Italy.

The Topics of Interest:
S1. Insulin resistance or hyperinsulinemia;
S2. Immunotherapy and adverse effects;
S3. Tumor microenvironment;
S4. Immune system, tumor immunology, and autoimmune disease;
S5. Biomedicine in cardiovascular diseases;
S6. Diabetes, obesity and metabolic diseases;
S7. Gene therapy and gene editing;
S8. Rare diseases;
S9. Molecular mechanisms of neurodegeneration.

Important Dates:
Deadline for abstract submission: 19 January 2025;
Notification of acceptance: 19 February 2025;
Deadline for free registration: 8 May 2025.

Submit your abstract here.

Register for the conference here.

For any inquiries regarding the event, please contact ecb@mdpi.com. We look forward to seeing you at ECB2025.

6 December 2024
MDPI INSIGHTS: The CEO's Letter #18 - MDPI UK, Basel Job Fair, CETEF'24

Welcome to the MDPI Insights: The CEO's Letter.

In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.


Opening Thoughts

MDPI’s First UK Summit Held in Manchester

On 29 November, we hosted our first annual MDPI UK Summit, bringing together over 30 Chief Editors and Editorial Board Members (EBMs) to discuss MDPI’s mission, achievements, and collaborations in the UK.

Throughout the day we had talks from several members of MDPI, roundtable discussions on the peer-review process and upholding research integrity, and an engaging presentation from the Editor-in-Chief (EiC) of MDPI journal Mathematics, Francisco Chiclana, about his involvement with the Research Excellence Framework.

“This was a great first summit for MDPI UK and received excellent feedback”

 In the following I highlight some of the sessions and the discussion topics covered in each session.

Session 1: Opening Speech and Introduction to MDPI

I shared an overview of MDPI’s mission, achievements, and commitment to quality. The Q&A touched on key topics such as perception and reputation management, expanding our arts and humanities portfolio, and funding challenges for open access (OA) in the UK.

A takeaway from this session was that in 2025, we will circulate a mini annual report to all editors, helping them understand MDPI’s mission and achievements beyond the context of their specific journals.

Session 2: MDPI and the Research Excellence Framework (REF)
Prof. Francisco Chiclana (EiC of Mathematics) highlighted MDPI’s role in REF, its purpose, and future directions.

Session 3: Editorial Process, Ethics, and Research Integrity
Dr. Giulia Stefenelli presented on the various editorial roles and responsibilities, quality metrics, and procedures for dealing with misconduct. The Q&A centred on AI in publishing, institutional roles in research integrity, and better data management practices.

Session 4: Institutional Open Access Program (IOAP)
Becky Castellon presented on IOAP benefits, including MDPI’s partnership with JISC, which includes more than 60 UK institutions, and highlighted the advantages of pure OA over transformative agreements.

Session 5: Round Table Discussion
Colleagues from our MDPI Manchester office Jaime Anderson and Dr. Michael O’Sullivan, along with colleagues from our Basel office Damaris Critchlow and Giulia Stefenelli, discussed innovations in peer review, challenges in maintaining scientific integrity, and future solutions.

Session 6: MDPI PR and the Voice of the Customer
I recapped our customer satisfaction drivers, including speed and editorial support. I also spoke about tackling misinformation about OA and MDPI in general, and outlined a way forward for us all to participate in advocating for open science.

This was a great first summit for MDPI UK and received excellent feedback from our EiCs, SEiCs, and EBMs. A BIG thank-you to our Manchester team (pictured below) and everyone else involved in organizing this event. Their hard work and dedication are much appreciated!

Impactful Research

MDPI and UK Publications

The UK is an important market for MDPI, ranking ninth in total submissions to MDPI and eighth in total MDPI publications, with over 72,200 publications to date. As at October 2024, there were more than 3,600 EBMs from the UK, 48% of whom have an H-index above 26. We also have 46 EiCs, and 63 SEiCs in the UK, some of whom joined us in Manchester for the UK Summit.

The UK is a strong advocate of OA publishing, with nearly three quarters of all articles in 2023 published on open access platforms. The country enjoys a large academic market, producing high-quality papers, and is home to some of the world’s top universities. Among MDPI’s 825 IOAP agreements, over 60 of these are in the UK, facilitated through our partnership with JISC.

“The UK is a strong advocate of OA publishing”

 Visit to MDPI’s Manchester Office

Last week, I visited our Manchester office to see the expanding office space, connect with our staff, and present at the MDPI UK Summit held in Manchester.

Throughout the day, I met with various teams to better understand their work and discuss their future development plans in greater depth. Hearing from group leads about the progress we have made and the challenges we face offered many valuable insights. I also had the chance to connect personally with members of the content team. It’s great to see how this young and ambitious team is coming together.

I also took the opportunity to address the entire office about the role of MDPI UK within the wider company. During this session, I answered questions about growth and public relations initiatives. Giulia Stefenelli joined us to address questions about the role of AI in MDPI’s future.

Jaime Anderson (Office Manager) and the Manchester team have done a great job of growing the office since its establishment in 2019. Today, it has around 150 staff members across various departments, including English editing, editorial services, marketing and communications, and IOAP. The team is highly active in local marketing initiatives, such as author training sessions, scholar visits, and conferences.

For more information and updates on our Manchester office, follow MDPI UK on LinkedIn.

Inside MDPI

Basel Job Fair

In November, the HR team from our Basel office connected with over 300 young professionals at the Basel Job Fair 2024. This is my biased opinion, of course, but we had the best branded booth and merchandise, which drew a lot of attention from young talent wanting to learn about current and future job opportunities at MDPI.

Our HR team also helped review CVs on the spot, providing advice on how to improve them and making a positive impression on the future workforce in Basel.

This is a reminder that MDPI is not only focused on supporting young researchers but that we also recruit and develop young talent. We have seen MDPI HR do this really well throughout all of our offices, from Asia Pacific to Europe and North America.

HR plays an important role in our growing company, helping us meet our recruitment targets as well as providing support for local teams, guidance on management and best practices, a safe space for employees, and brand recognition for MDPI, among many other things.

“MDPI is not only focused on supporting young researchers: we also recruit and develop young talent”

This is a quick appreciation post to all HR staff working to support MDPI and our colleagues, cultivating talent and supporting careers at every stage. Thanks HR staff, keep up the great work!

Coming Together for Science

Pharmaceuticals 2024 – Recent Advances in Pharmaceutical Sciences Towards a Healthy Life (The 20th Anniversary)

I am pleased to share that the Pharmaceuticals 2024 – Recent Advances in Pharmaceutical Sciences Towards a Healthy Life took place from 27 to 29 November 2024 in Barcelona, Spain. It was chaired by Prof. Dr. Amelia Pilar Rauter from the Universidade de Lisboa, Portugal; Dr. Alfredo Berzal Herranz from Instituto de Parasitología y Biomedicina López-Neyra (IPBLN) CSIC, Spain; and Prof. Dr. Mary Jane Meegan from Trinity College Dublin, Ireland.

The conference took place in Casa Convalescència, a part of the Sant Pau Art Nouveau Site. The three-day event included three plenary sessions and eight invited speakers, from eight countries, and 29 selected talks. Of the presentations on site, there were 32 posters and 29 oral presentations.

The main goal of the ‘Pharmaceuticals 2024’ international conference was to cover the newest technologies and research areas including medicinal chemistry, natural products, organic synthesis, radiopharmaceuticals, pharmacology, toxicology, and biomolecular and glycosciences, in a meeting that brought together experts to present their latest findings on combatting infection, inflammation, pain, and neurodegeneration, to mention just a few of the topics that were discussed.

“The main goal of ‘Pharmaceuticals 2024’ was to cover the newest technologies and research areas”

20th Anniversary of Pharmaceuticals

The year 2024 marks the 20th anniversary of Pharmaceuticals – a journal dedicated to medicinal chemistry and related drug sciences, which is published monthly online by MDPI. To honour this milestone, we are reflecting on our past accomplishments and embarking on an exciting new chapter. This celebration is also one of the reasons why we organized the conference Pharmaceuticals 2024. With an Impact Factor of 4.3 and a CiteScore of 6.1, the journal is covered in Scopus, SCIE (Web of Science), PubMed, PMC, Embase, CAPlus/SciFinder, and other databases. Pharmaceuticals has published over 6,000 papers from more than 37,000 authors. More than 10,000 reviewers have reviewed for it at least once.

20th Anniversary of Pharmaceuticals: The Video

This video captures the experiences of the conference chairs, honorary guests and committee members of the conference.

 

Thank you to our partnering societies

A special thank-you is due to our partnering societies the Spanish Society Of Medicinal Chemistry (SEQT) and the Spanish Society For Biochemistry And Molecular Biology (SEBBM) for their support of the Pharmaceuticals 2024 conference. I am also pleased to report that we presented two awards, sponsored by the journal Pharmaceuticals, including the Best Presentation Award and the Best Oral Presentation Award, recognizing the contributions of our participants.

Closing Thoughts

Presenting at the 4th Central European Technology Forum

I visited Krakow, Poland in November to participate in the 4th Central European Technology Forum (CETEF’24), which took place on 18 and 19 November.

CETEF is an international conference that has been jointly organized since 2014 by the Polish Chamber of Commerce for Advanced Technologies (IZTECH) and the Polish Federation of Engineering Associations, with the support of the European Parliament and the European Commission, in cooperation with universities, research institutes and the high-tech industry. The 2024 event focused on presentation to advance the European science and technology agenda for 2025–2030.

MDPI participated as a key publishing sponsor. We had an exhibition booth and held two key presentations during the conference. On Monday, I presented MDPI’s vision, purpose, and achievements.

On Tuesday, Dr. Giulia Stefenelli shared how MDPI supports advancements in high technology and energy transition, highlighting our portfolio, services, tools and initiatives for promoting progress and interdisciplinary collaboration.

We received positive feedback from scientists and government representatives in attendance.

A big thank-you goes to our colleagues from the Krakow office for their support in organizing our participation and managing the MDPI booth.

Special thanks are owing to Weronika Gorka-Kumik, Igor Matic, Vincent Di, Agnieszka Rydz, Ksenia Shubenkova, Anna Krakowka and Klaudia Kasprowicz.

Below is a photo with the President of the Polish Chamber of Commerce conference (centre), along with MDPI colleagues Giulia Stefenelli, Weronika Gorka-Kumik, and Igor Matic (left to right).

“This year’s event focused on ideas and proposals to advance the European science and technology agenda for 2025–2030”

Stefan Tochev
Chief Executive Officer
MDPI AG

4 December 2024
685 MDPI Editors Named Highly Cited Researchers in 2024


We extend our heartfelt congratulations to the 685 Editorial Board Members of our journals – from 39 different countries and territories – who have been recognized as Highly Cited Researchers for 2024 by Clarivate. This distinction highlights their exceptional scientific achievements and significant contributions, which transcend academic boundaries to advance global knowledge, sustainability, security, and well-being.

Clarivate's annual Highly Cited Researcher™ list identifies the most influential scientists of the past decade, whose work has had a profound and widespread impact across various scientific and social science disciplines. Their impactful papers rank among the top 1% by citations in one or more of the 21 fields analyzed within the "Essential Science Indicators," marking them as leaders in their respective domains.

"Highly Cited Researchers have demonstrated significant and broad influence in their field(s) of research," according to Clarivate. In 2024, a total of 6,886 Highly Cited Researcher designations were awarded to 6,636 individuals.

The following is a list of MDPI's Editorial Board Members named Highly Cited Researchers in 2024. We congratulate them for their achievement and their contributions to advancing knowledge in their respective fields.


Abate, Antonio
Abbate, Antonio
Aguilera, Ruth V.
Ahmed, Warish
Ahn, Myung-Ju
Ambretti, Simone
Anasori, Babak
Andersson, Dan I.
Annabi, Nasim
Antinori, Spinello
Arbabi, Amir
Ariga, Katsuhiko
Astruc, Didier
Bajpai, Vivek K.
Balaj, Leonora
Balsamo, Gianpaolo
Bando, Yoshio
Banks, William A.
Barnes, Peter J.
Barnholtz-Sloan, Jill S.
Barros, Lillian
Bashir, Ali Kashif
Basit, Abdul W.
Bassetti, Matteo
Batley, Jacqueline
Battino, Maurizio
Benediktsson, Jon Atli
Bjarnsholt, Thomas
Blaschke, Thomas
Blay, Jean-Yves
Blumwald, Eduardo
Blunt, John W.
Bonomo, Robert A.
Bourke, Paula
Boyd, Robert W.
Boyer, Cyrille
Bruyere, Olivier
Bu, Wenbo
Bush, Ashley I.
Byrd, John C.
Cabeza, Luisa F.
Cai, Baoping
Cai, Lei
Cai, Xingjuan
Cambria, Erik
Cao, Guozhong
Cao, Xingzhong
Carvalho, Andre F.
Chan, Jasper Fuk-Woo
Chan, Timothy A.
Chao, Dongliang
Chen, Bin
Chen, Bo
Chen, Chaoji
Chen, Fahu
Chen, Hualan
Chen, Jun
Chen, Kunsong
Chen, Lidong
Chen, Lingxin
Chen, Mou
Chen, Peng
Chen, Qianwang
Chen, Shaowei
Chen, Shuai
Chen, Shuangming
Chen, Xiangyu
Chen, Xiao
Chen, Xiaobo
Chen, Xu
Chen, Yimin
Chen, Yulin
Cheng, Gong
Cheng, Huanyu
Cheng, Laifei
Cheng, Qiang
Chiclana, Francisco
Choi, Wonyong
Choi, Young Hae
Chowdhary, Anuradha
Clevers, Hans
Collins, Maurice N.
Cortes, Javier
Cortes, Jorge
Cottin, Vincent
Creutzig, Felix
Crommie, Michael F.
Cuadrado, Antonio
Cui, Yi
Dai, Hongjie
Dai, Shifeng
Daiber, Andreas
Davis, Steven J.
Davis, Thomas P.
Dawson, Ted M.
de Vries, Rory D.
de Vries, Wim
Deng, Xiangzheng
Desneux, Nicolas
Ding, Aijun
Ding, Jianxun
Dokmeci, Mehmet Remzi
Dolgui, Alexandre
Dou, Shi Xue
Dragicevic, Tomislav
Du, Bo
Du, Qian
Du, Yonghua
Duan, Xidong
Dufresne, Alain
Dummer, Reinhard
Ebi, Kristie L.
Edwards, David
Enjuanes, Luis
Fabbro, Doriano
Facchetti, Antonio
Fan, Junliang
Fan, Kelong
Fan, Xiulin
Fang, Chuanglin
Fang, Jingyun
Fang, Yongjin
Fasano, Alessio
Felser, Claudia
Feng, Xuning
Ferdinandy, Péter
Filippi, Massimo
Flavian, Carlos
Fortino, Giancarlo
Fowler, Michael
Franceschi, Claudio
Fu, Gengtao
Fu, Yongshuo
Fujita, Hamido
Gagaoua, Mohammed
Gai, Francesco
Gaisford, Simon
Galano, Annia
Galluzzi, Lorenzo
Galvano, Fabio
Gao, Huijun
Gao, Huile
Gao, Junkuo
Gao, Peng
Garbe, Claus
Garcia, Hermenegildo
Gasbarrini, Antonio
Genevet, Patrice
Geng, Yong
Gerdts, Gunnar
Geschwind, Daniel H.
Ghaffari, Roozbeh
Ghamisi, Pedram
Giampieri, Francesca
Gobbetti, Marco
Godos, Justyna
Gogotsi, Yury
Golding, Nick
Gong, Jinlong
Gong, Peng
Gotor, Cecilia
Govindan, Kannan
Grancini, Giulia
Grant, William B.
Graus, Francesc
Green, Douglas R.
Greenberg, Dan
Grigoriev, Igor
Grosso, Giuseppe
Gu, Zhanjun
Guan, Cao
Gueimonde, Miguel
Gui, Guan
Guo, Hengyu
Guo, Jianping
Guo, Jinghua
Guo, Song
Guo, Zaiping
Gutzmer, Ralf
Győrffy, Balázs
Haase, Dagmar
Hagger, Martin S.
Han, Buxing
Han, Fudong
Han, Heesup
Hanes, Justin
Hao, Junnan
He, Bao-Jie
He, Chi
He, Debiao
He, Hongwen
He, Jiaqing
He, Jr-Hau
He, Ping
He, Xiangming
He, Xijun
He, Zhili
Heinrich, Michael
Heneka, Michael Thomas
Henry, Brandon Michael
Herrera, Francisco
Herrera-Estrella, Luis
Hilal, Nidal
Hong, Danfeng
Hossain, Ekram
Hu, Enyuan
Hu, Jin-Song
Hu, Wenbin
Hu, Xiaosong
Huang, Bo
Huang, Haitao
Huang, Hongwei
Huang, Jianping
Huang, Qing
Huang, Yan
Huang, Yu
Hubacek, Klaus
Hwang, Jinsoo
Italiano, Antoine
Iwata, Hiroji
Izzo, Angelo A.
Jaiswal, Amit K.
Jankovic, Joseph
Jelezko, Fedor
Jeon, Byong-Hun
Ji, Jian
Ji, Xiaobo
Ji, Xiaoyuan
Jiang, Lei

Jiang, Lianzhou
Jiang, Shibo
Jiang, Yuji
Jiang, Yuyan
Jiang, Zhongyi
Jiao, Licheng
Jin, Hailing
Jin, Yuanxiang
Jin, Zhengyu
Jin, Zhong
Jing, Qingshen
Kalantar-zadeh, Kourosh
Kamal, Mohammad Amjad
Kaneti, Yusuf Valentino
Kang, Xudong
Kang, Zhenhui
Karagiannidis, George K.
Karki, Rajendra
Karniadakis, George Em
Kataoka, Kazunori
Katritch, Vsevolod
Kawi, Sibudjing
Kepp, Oliver
Khademhosseini, Ali
Kiessling, Fabian
Kim, Jong Seung
Kim, Jong-Hoon
Kim, Sung-Bae
Kim, Sunghwan
Kirkwood, John M.
Kivshar, Yuri
Klein, Christian
Klenk, Hans-Peter
Koh, Lenny
Kong, Baohua
Krause, Robert
Kroemer, Guido
Kudo, Masatoshi
Kumar, Anil
Kumar, Prashant
Kumar, Sudhir
Kurths, Juergen
Kurzrock, Razelle
Kyrpides, Nikos C.
La Vecchia, Carlo
Lam, Tommy Tsan-Yuk
Lan, Ke
Lancellotti, Patrizio
Landi, Francesco
Landi, Marco
Lavie, Carl J.
Lee, Chengkuo
Lee, Jin-Wook
Lee, Pooi See
Lehmann, Johannes
Lei, Yaguo
Li, Bing
Li, Chunzhong
Li, Dawei
Li, Dongfang
Li, Dongsheng
Li, Jingchao
Li, Jing-Feng
Li, Jinghong
Li, Linlin
Li, Meng
Li, Neng
Li, Ning
Li, Shutao
Li, Xiang
Li, Xuecao
Li, Yaping
Li, Yat
Li, Yong
Li, Yonghui
Li, Yurui
Liang, Hanfeng
Liang, Shuquan
Lin, Jun
Lin, Yi
Lin, Yuehe
Lippi, Giuseppe
Liu, Chengmei
Liu, Feng
Liu, Hong
Liu, Hongyu
Liu, Jian-Kui (Jack)
Liu, Meilin
Liu, Min
Liu, Shujuan
Liu, Xianhu
Liu, Xiaoping
Liu, Xuejun
Liu, Yu
Loh, Xian Jun
Long, Guankui
Long, Hualou
Long, Ying
Lu, Jianquan
Lu, Junling
Lu, Nanshu
Lu, Shun
Lu, Yingying
Lugato, Emanuele
Lund, Henrik
Luo, Jie
Luo, Jingshan
Luo, Yangchao
Luo, Zisheng
Lutolf, Matthias P.
Lv, Wei
Lyons, Timothy W.
Ma, Chao
Ma, Tianyi
Ma, Yanming
Mahmood, Nasir
Mahmoudi, Morteza
Mandalà, Mario
Mao, Jianfeng
Mao, Like
Martin-Belloso, Olga
Martinez, Luis
Mateos, Maria Victoria
Mathiesen, Brian Vad
Matyjaszewski, Krzysztof
McCauley, Darren
Mei, Lin
Melenhorst, Jan Joseph
Melero, Ignacio
Meyerholz, David K.
Miao, Song
Miroshnichenko, Andrey E.
Mittler, Ron
Montagne, Axel
Moreau, Philippe
Mu, Shichun
Muhammad, Khan
Mulligan, Mark J.
Mumtaz, Shahid
Nauen, Ralf
Nemeroff, Charles B.
Niaura, Raymond S.
Nussinov, Ruth
Oganov, Artem R.
Oh, Deog Hwan
O'Reilly, Eileen M.
Ouyang, Minggao
Ozcan, Aydogan
Pacher, Pal
Pan, Anlian
Pan, Anqiang
Pan, Caofeng
Pan, Genxing
Pan, Xiaoqing
Parati, Gianfranco
Peng, Qiang
Peng, Qing
Peng, Shushi
Perlin, David S.
Perlman, Stanley
Petruzzelli, Antonio Messeni
Peyrin-Biroulet, Laurent
Pitt, Bertram
Pöhlmann, Stefan
Polasky, Stephen
Pommier, Yves
Poor, H. Vincent
Portincasa, Piero
Potenza, Marc N.
Prinsep, Michele R.
Pu, Hongbin
Pu, Kanyi
Putnik, Predrag
Qi, Jianping
Qiang, Yujie
Qin, Yuanwei
Qiu, Jieshan
Qu, Xiaogang
Ragauskas, Arthur J.
Ramkissoon, Haywantee
Ran, Jingrun
Rao, Zhonghao
Ren, Jinsong
Rengel, Zed
Rezania, Shahabaldin
Rho, Junsuk
Riahi, Keywan
Ribeiro-Soriano, Domingo
Richardson, Paul G.
Rignot, Eric
Robert, Caroline
Rocca, Maria A.
Rodriguez-Manas, Leocadio
Rojas, Orlando J.
Rojo, Teofilo
Rossolini, Gian Maria
Saad, Walid
Saif, Linda J.
Saliba, Michael
Sander, Chris
Saso, Luciano
Scaldaferri, Franco
Schafer, Alexandra
Schatzberg, Alan F.
Schwab, Matthias
Scolyer, Richard A.
Scorrano, Luca
Scott, Stuart A.
Serruys, Patrick W.
Shao, Minhua
Shao, Shuai
Shao, Zongping
Shen, Guozhen
Shen, Liyin
Shen, Zexiang
Shi, Kai
Shi, Pei-Yong
Shi, Peng
Shi, Yi
Shin, Hyeon Suk
Shin, Su Ryon
Siano, Pierluigi
Simões, Manuel
Simpson, Richard J.
Sing, Swee Leong
Singh, Vijay P.
Skouta, Rachid
Smagghe, Guy

Song, Jibin
Song, Yanlin
Sood, Anil K.
Souto, Eliana B.
Speiser, Daniel E.
Stadler, Marc
Stephanopoulos, Gregory
Sternberg, Cora N.
Stoumpos, Constantinos C.
Su, Chao
Su, Dong
Sun, Cuixia
Sun, Fengchun
Sun, Guangyong
Sun, Jian
Sun, Litao
Sun, Xian
Sun, Zaicheng
Sun, Zhipei
Sureda, Antoni
Svenning, Jens-Christian
Tan, Chaoliang
Tang, Ben Zhong
Tang, Chuan-He
Tang, Chuyang
Tang, Dianping
Tang, Yawen
Tang, Yongbing
Tanzi, Rudolph E.
Tao, Yang
Teichmann, Sarah
Telenti, Amalio
Tian, He
Tian, He
Timsit, Jean-Francois
Tohge, Takayuki
Tran, Lam-Son Phan
Tress, Wolfgang
Trivedi, Pankaj
Tsao, Rong
Tsuda, Kenichi
Tukker, Arnold
Tung, Chen-Ho
van der Werf, Guido
Van Mierlo, Joeri
Vandenbroucke, Roosmarijn E.
Varsani, Arvind
Vatanen, Tommi
Verbeke, Kristin
Verpoorte, Robert
Vieta, Eduard
Vincent, Jean-Louis
Vinu, Ajayan
Vita, Antonio
Wagner, Wolfgang
Walters, William
Wan, Jiafu
Wanek, Wolfgang
Wang, Chunsheng
Wang, Dawei
Wang, Dongdong
Wang, Fang
Wang, Fayuan
Wang, Gongming
Wang, Guoxiu
Wang, Haihui
Wang, Huanting
Wang, John
Wang, Joseph
Wang, Lianzhou
Wang, Lihui
Wang, Qi
Wang, Qingsong
Wang, Rui
Wang, Shaojian
Wang, Sibo
Wang, Tao
Wang, Wenguan
Wang, Yanbo
Wang, Yong
Wang, Yonghong
Wang, Yu
Wang, Zhiyu
Wang, Zhong Lin
Wang, Zhongrui
Wang, Zifa
Wang, Ziyun
Wang, Zuankai
Wedzicha, Jadwiga
Wei, Haotong
Wei, Leyi
Wei, Mingyang
Wei, Zhixiang
Wei, Zhongbao
Weiskirchen, Ralf
Weissleder, Ralph
Wen, Guanghui
Wenwu, Yu
Wesemael, Bas van
Witlox, Frank
Wu, Di
Wu, Haijun
Wu, Hao
Wu, Hao Bin
Wu, Jianzhong
Wu, Lifeng
Wu, Qinglin
Wu, Shuilin
Wu, Tom
Wu, Yongning
Wu, Yongzhen
Wu, Yuping
Wu, Zheng-Guang
Wu, Zhong-Shuai
Xia, Jianguo (Jeff)
Xia, Xinhui
Xia, Xiufang
Xia, Yongyao
Xia, Zhiguo
Xiang, Quanjun
Xin, Sen
Xing, Wei
Xiong, Rui
Xu, Jianping
Xu, Li Da
Xu, Ping
Xu, Wu
Xu, Xiaomin
Xu, Xiaopeng
Xu, Zhenjiang Zech
Yan, Chong
Yan, Jun
Yan, Qingyu
Yang, Chenguang
Yang, Hongshun
Yang, Jianping
Yang, Shihe
Yang, Wei
Yang, Xin-She
Yang, Xinsong
Yang, Yongqing
Yang, Yun-Gui
Yao, Yonggang
Ye, Jun
Yin, Shen
Yin, Shou-Wei
Yin, Yulong
Yin, Zongyou
Yokoya, Naoto
Young, Allan H.
Yu, Bin
Yu, Guihua
Yu, Minghao
Yu, Shu-Hong
Yuan, Qiangqiang
Yuan, Yifei
Yue, Dong
Yue, Wenze
Zeadally, Sherali
Zeng, Xiaoxiong
Zhai, Guangtao
Zhai, Tianyou
Zhang, Anna Jinxia
Zhang, Bin
Zhang, Fang
Zhang, Fucang
Zhang, Fusuo
Zhang, Guangyu
Zhang, Guoqing
Zhang, Hengjie
Zhang, Jian
Zhang, Kai
Zhang, Lefei
Zhang, Liangpei
Zhang, Linqi
Zhang, Qiaobao
Zhang, Shanqing
Zhang, Shaoqing
Zhang, Shujun
Zhang, Tierui
Zhang, Wenjun
Zhang, Xian-Ming
Zhang, Xiaodong
Zhang, Xiaoling
Zhang, Yi-Zhou
Zhang, Yong-Wei
Zhang, Yu Shrike
Zhang, Yu-Dong
Zhang, Yue-Jun
Zhang, Yuelin
Zhang, Zhien
Zhao, Biao
Zhao, Guochun
Zhao, Jie
Zhao, Kangning
Zhao, Li-Dong
Zhao, Qing
Zhao, Yi
Zhavoronkov, Alex
Zheng, Hao
Zheng, Weitao
Zheng, Yufeng
Zhong, Cheng
Zhong, Yanfei
Zhou, Di
Zhou, Feng
Zhou, Jizhong
Zhou, Kun
Zhou, Lei
Zhou, Liang
Zhou, Peng
Zhou, Weijia
Zhou, Weiqi
Zhou, Yanhong
Zhou, Yuyu
Zhou, Zhigang
Zhu, Chengzhou
Zhu, Hongwei
Zhu, Junfa
Zhu, Jun-Jie
Zhu, Yongfa
Zhu, Zhe
Zhuang, Xiaodong
Zipfel, Stephan
Zou, Guoqiang
Zou, Ruqiang
Zoulim, Fabien
Zuo, Chao

26 November 2024
Meet Us at the 12th Singapore International Chemistry Conference, 9–13 December 2024, Singapore


The 12th Singapore International Chemistry Conference (SICC-12) is scheduled to be held on 9 to 13 December 2024. It is hosted by the Singapore National Institute of Chemistry (SNIC) and it will cover organic, organometallic, inorganic and material chemistry. The theme will be “Building Chemistry: Bridging Disciplines” and about 2000 participants from all over the world are expected. We have already gathered an impressive roster of speakers, including Nobel Laureate Professor Aaron Ciechanover. This event will be held in-person only, in Singapore.

The following MDPI journals will be represented at the conference:

If you are planning on attending this conference, please do not hesitate to stop by our booth and start a conversation with us. Our delegates look forward to meeting you in person and answering any questions that you may have. For more information about the conference, please visit the following website: https://sicc12.org/.

25 November 2024
The 5th International Conference on Symmetry (Symmetry 2025)—Open for Submissions


We are pleased to announce that the 5th International Conference on Symmetry (Symmetry 2025) is scheduled to take place from 16 to 19 May 2025 in Hangzhou, China. The conference, organized by MDPI’s Symmetry (ISSN: 2073-8994, Impact Factor: 2.2), aims to gather researchers, professionals, and experts interested in this field to share their latest research findings, innovations, and experiences.

For this upcoming event, we are proud to announce the following conference chairs and plenary speakers.

Conference Chairs:

  • Dr. Sergei D. Odintsov, Institute of Space Sciences, Spain;
  • Dr. Changzheng Qu, Ningbo University, China;
  • Dr. Jihuan He, Soochow University, China.

Plenary Speakers:

  • Dr. Ronggen Cai, Ningbo University, China;
  • Dr. Sergei D. Odintsov, Institute of Space Sciences, Spain;
  • Dr. Jiping Zhang, Peking University, China.

Topics of Interest and Session Chairs:
S1. Physics

  • Session Chair: Shin'ichi Nojiri, Nagoya University, Japan;
  • Session Chair: Prof. Tianjun Li, Chinese Academy of Sciences; Henan Normal University, China;
  • Session Chair: Prof. Yuxiao Liu, Lanzhou University, China.

S2. Mathematics

  • Session Chair: Prof. Qingwen Wang, Shanghai University, China;
  • Session Chair: Prof. Shoufeng Shen, Zhejiang University of Technology, China.

S3. Chemistry

  • Session Chair: György Keglevich, Budapest University of Technology and Economics, Hungary;
  • Session Chair: Prof. Weihua Tang, Xiamen University, China.

S4. Engineering

  • Session Chair: Prof. Chong Wang, Beihang University China, China;
  • Session Chair: Prof. Deming Lei, Wuhan University of Technology, China.

S5. Computer Science

  • Session Chair: Prof. Hu Xiong, University of Electronic Science and Technology of China, China;
  • Session Chair: Prof. Kuo-Hui Yeh, National Yang Ming Chiao Tung University, Taiwan.

S6. Symmetry Applications

  • Session Chair: Prof. Jihuan He, Soochow University, China;
  • Session Chair: Prof. Chunli Zhang, Zhejiang University, China.

Conference Awards:

  • Best Oral Presentation Award;
  • Best Poster Award;
  • Best Speaker Award.

Number of winners: 23.

Prizes:
CNY 1500 (5 winners); a full Article Processing Charge (APC) waiver for Symmetry (6 winners); a 50% APC waiver for Symmetry (12 winners); and a certificate celebrating this achievement (all winners).

Guide for Authors:
To submit your abstract, please click on the following link:
https://sciforum.net/user/submission/create/1219.

To register for the event, please click on the following link:
https://sciforum.net/event/symmetry2025?section=#registration.

For more information, you may refer to the following:
https://sciforum.net/event/symmetry2025?section=#instructions.

Important Dates:
Abstract Submission Deadline: 16 February 2025
Notification of Acceptance: 9 March 2025
Early-Bird Registration: 16 March 2025
Registration Deadline: 16 May 2025

We look forward to receiving your contribution to Symmetry 2025.

Conference Chairs
Symmetry 2025 Organizing Team (symmetry2025@mdpi.com)

15 November 2024
Prof. Dr. A. Douglas Kinghorn Appointed Chair of the 2024 Tu Youyou Award Committee


We are honored to announce that Prof. Dr. A. Douglas Kinghorn will serve as the Chair of the 2024 Tu Youyou Award Committee.

Name: Prof. Dr. A. Douglas Kinghorn
Affiliation: College of Pharmacy, The Ohio State University, USA

Prof. Dr. Kinghorn is a leading expert in pharmacognosy and natural products research. He is recognized for his key contributions to discovering bioactive compounds from plants, especially in anticancer, cancer chemopreventive, and substances with a sweet taste and taste-modifying agents. His prolific contributions include over 590 peer-reviewed works and edited or co-edited 40 scientific volumes.

The 2024 Tu Youyou Award Committee, under Prof. Dr. Kinghorn's guidance, will focus on identifying innovative research in the fields of natural products chemistry and medicinal chemistry. The committee will aim to identify groundbreaking work with the potential to lead to significant advancements in these areas.

We are confident that, with Prof. Dr. Kinghorn at the helm, the 2024 Tu Youyou Award will continue to inspire excellence and innovation in the related fields.

About the Tu Youyou Award
Established in 2016, the Tu Youyou Award seeks to honor those who excel in the fields of natural products chemistry and medicinal chemistry. This award offers a total prize of CHF 100,000, which will be equally divided among the winners if there is more than one, with each recipient receiving an award medal.

The 2024 Tu Youyou Award remains open for nominations until 31 December 2024. We encourage all eligible candidates to participate in this prestigious recognition, as this award not only honors individual achievement but also encourages further scientific exchange, exploration and discovery in critical areas of medicine.

If you are interested in participating, please visit the Tu Youyou Award website for more information on the nomination requirements.

13 November 2024
Molecules Webinar | Recent Advances in Redox Active Species, 28 November 2024


MDPI invites all esteemed experts to join the webinar of Molecules (ISSN: 1420-3049) titled “Recent Advances in Redox Active Species”. This webinar will delve into the latest breakthroughs in redox biology, focusing on reactive nitrogen, sulfur, and selenium species and their complex roles in cellular function. These reactive species serve as both damaging agents and essential signaling molecules, making them central to our understanding of disease mechanisms and potential therapeutic strategies.

We look forward to your participation in this discussion. 

Title: Recent Advances in Redox Active Species
Date: 28 November 2024
Time: 09:00 a.m.–10:35 a.m. (CET) | 04:00 p.m.–05:35 p.m. (CST Asia)

This is a free webinar. After registration, you will receive a confirmation email containing information on how to join. Registrations with academic institutional email addresses will be prioritized. 

Unable to attend? Register anyway and we will let you know when the recording is available for viewing.


Register for free:

Program:

Speaker/Presentation

Time in CET

Time in CST (Asia)

Prof. Dr. Claus Jacob
Chair Introduction

 

09:00–09:05

16:00–16:05

Prof. Gregory Giles
Modulation of Reactive Nitric Oxide in Drug Discovery: Photoresponsive Systems for Precision Control

09:05–09:30

16:05–16:30

Q&A Session

09:30–09:35

16:30–16:35

Prof. Cecilia Battistelli
Selenotriazines: A Path to Neuroprotection and Treatment of Alzheimer's Disease

9:35–10:00

16:35–17:00

Q&A Session

10:00–10:05

17:00–17:05

Dr. Ahmad Yaman Abdin
Roundtable Session

10:05–10:30

17:05–17:30

Prof. Dr. Claus Jacob
Closing of Webinar

10:30–10:35

17:30–17:35

12 November 2024
MDPI Thailand Author Training Session at Kasetsart University Held on 5 November 2024

MDPI successfully held an author training session at Kasetsart University, Thailand's leading agricultural institution. This event took place against the backdrop of Kasetsart University's participation in MDPI’s Institutional Open Access Program (IOAP). The session, which was conducted on 5 November 2024, aimed to equip students with the essential knowledge and skills for maneuvering through the paper publication process, enhancing their English writing proficiency, understanding data visualization in academic papers, and exploring the applications of artificial intelligence in the publishing field.

Ms. Watinee Khemakarothai, the Deputy Director of Kasetsart University Library, shared her thoughts on the valuable collaboration between Kasetsart University (KU) and MDPI, emphasizing the significance of joint efforts that support and empower the academic community. She expressed her gratitude to MDPI Thailand for organizing this event, which was customized to meet the requirements of the university’s authors.

In the first presentation, Dr. Janenipa Saupsor, the Deputy Office Manager of MDPI Thailand, provided insights into MDPI’s development from its establishment in 1996 to its current status as a prominent open access academic publisher. She emphasized MDPI’s dedication to making scientific research freely accessible through its extensive collection of over 400 journals and its global presence. Dr. Saupsor also introduced a selection of key journals, such as Polymers, Sustainability, Foods, Animals and Molecules, which serve as valuable options for researchers seeking the ideal journal for their work. Additionally, she highlighted the successful collaboration between MDPI and Kasetsart University on the Institutional Open Access Program (IOAP), reinforcing support for open access publishing.

The second session, presented by Ms. Ploy Assavajamroon, MDPI’s regional journal relations specialist in Asia-Pacific, was titled “How to Write Scientific Papers in English”. The session began with the literature search and introduction to the analysis program to investigate the research topic to ensure novelty. Next, she illustrated the front matter, main text, and back matter, the three fundamental manuscript structures, before sharing useful examples to help the audience better understand how to write each section. Last but not least, she introduced the English Language Editing and Figure Editing services provided by MDPI Author Services, all of which support authors in manuscript preparation.

The third session, “Data Visualization for Scientific Papers”, was shared by Mr. Suvicha Sasivimolkul, MDPI’s Training Group Leader for Asian offices. He initiated the session by pointing out why data are so crucial due to the increasing amounts of data every minute. Data visualization is an approach through which we can maintain our perceptual and cognitive abilities to understand trends and patterns of the data by presenting data graphically in figures, graphs, or tables. He then explained and emphasized MDPI Figure and Table formatting, the points that the author should pay more attention to and the points that the author should avoid.

The author training program concluded with the topic “Artificial Intelligence (AI) in Scientific Publishing”, presented by Dr. Kamolchanok Deesrisak, Scientific Advisor of MDPI journal Healthcare. After providing an overview of AI technology in daily life, its capabilities and impacts on scientific publishing were elaborated, with a focus on the current advancements and challenges. In line with the Committee on Publication Ethics (COPE) position statement, the guidelines on AI, authorship, and the peer-review process were thoroughly explained. Before ending the session, the AI tools developed by MDPI's AI team were introduced. These will assist both internal and external users in improving processes and services.

After each presentation, students, faculty members, and MDPI speakers engaged in a vigorous exchange of ideas. Even after the training, many attendees remained and continued to communicate with us, praising the event for its well-structured curriculum and the opportunity to network with like-minded professionals.

In conclusion, the author training session at Kasetsart University marked a crucial step in promoting academic publishing and research dissemination for MDPI. Meanwhile, it emphasized the importance of continuous learning and adaptation in the constantly evolving landscape of higher education and the publishing industry. This initiative represented a reinforcement.

Please do not hesitate to start a conversation with us at bangkok@mdpi.com if you would like to hold an author training session with MDPI in Thailand.

 

Back to TopTop